AEGiS-GMHC: New York AIDS Trial Sites Cancelled

Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

New York AIDS Trial Sites Cancelled

Gay Men's Health Crisis: Treatment Issues, Volume 8 no. 9 - October 1994
Saundra Johnson

The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) has defunded three of its four New York City sites. This action puts in jeopardy New York's ability to offer HIV/AIDS clinical trials to underserved populations, a goal included in the CPCRA mission statement. The CPCRA, which is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), is a network of sixteen community-based organizations that is supposed to carry out studies of new treatments within the context of ordinary medical care.

The decision is the result of a "recompetition" in which participating groups and proposed new groups were evaluated to find which can best fulfill the CPCRA's mission. In all, four organizations lost their funding. The defunded New York City groups are: the Addiction Research and Treatment Corporation in Brooklyn, Bronx Lebanon Hospital Center, and Clinical Directors Network of Region II, which is based in Manhattan and also has sites in Newark.

The canceled New York sites account for 59.6 percent of the total number of Latinos, 26.7 percent of the total number of African Americans, 39.7 percent of the total number of women, and 47.2 percent of the total number of injection drug users enrolled in CPCRA trials nationally. Moreover, achieving the planned enrollment in the tuberculosis prophylaxis and treatment trials will be impossible without further accrual at the New York sites.

NIAID has convened a task force to determine the effect the defunding will have on TB trials in New York and nationally. In addition, state and local officials have questioned the fairness of the peer selection process that reviewed the performance of CPCRA units and are demanding an investigation of how this process was conducted.

Copyright (c) 1994 - Gay Men's Health Crisis. Noncommercial reproduction encouraged. DISTRIBUTED BY GENA/aegis * 8N1/Full Duplex * v.34 * 714.248.2836.
9410
GMHI8906

Copyright © 1994 - Treatment Issues. Reproduced with permission. Treatment Issues is published twelve times yearly by GMHC, Inc. All rights reserved. Noncommercial reproduction is encouraged. Subscription lists are kept confidential. GMHC Treatment Issues, The Tisch Building, 119 West 24th Street, New York, NY 10011 fredg@gmhc.org http://www.gmhc.org

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .